NCT07645638Completed
Virtual Reality Cognitive Stimulation for Alzheimer's
Cognitive Stimulation and Memory Enhancement Through Virtual Reality in Patients With Alzheimer's Disease: A Behavioral, Biometric, and Neurocognitive Assessment
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
This study aims to evaluate whether immersive virtual reality (VR) can improve cognitive function and memory in patients with Alzheimer's disease. Twenty participants in Burgos, Spain, will engage in VR sessions that recreate scenes from 1960s Burgos, representing environments familiar from the participants' youth. The effects of these VR-based cognitive stimulation sessions will be assessed through pre- and post-intervention evaluations, including behavioral observations, EEG monitoring of brain activity, and standardized neurocognitive tests (Montreal Cognitive Assessment, Clock-Drawing Test, and Verbal Fluency Test).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 29 May 2026
- Start date
- 8 Jan 2025
- Primary completion date
- 20 Mar 2025
- Lead sponsor
- Universidad de Burgos
- Diseases
- Alzheimer disease
- NCT number
- NCT07645638
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 8 Jan 2025 to the primary completion date, 20 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of other neurodegenerative disorders (e.g., Parkinson's disease, Huntington's disease, multiple sclerosis).
- History of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder).
- Severe vision or hearing impairment that cannot be corrected (e.g., legal blindness).
- History of epilepsy, seizure disorders, or other conditions that may be aggravated by VR exposure.
- Active skin conditions or infections that prevent the use of a VR headset or EEG sensors.
Other
- Participation in another interventional clinical trial within the last 30 days.
Who the study is looking for
- Diagnosed with mild cognitive impairment
- Aged 60 years or older.
- Resident or attending care at the Alzheimer's care center in Burgos.
- Capable of providing informed consent, either directly or through a legally authorized representative.
- Adequate vision and hearing (corrected if necessary) to engage with the VR experience.
- Able to tolerate wearing a VR headset for sessions of approximately 15-30 minutes.
Age in the registry: 60 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Burgos Coordinator of this site? Confirm its status | Burgos | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.